Accès ouvert
2026
article
OpenAlex
Antoine Harvengt, Gauthier Pirlot, Leyan Denizli, Zain Syed et autres
BACKGROUND: Type 1 diabetes (T1D) shares clinical characteristics with other forms of diabetes, particularly monogenic diabetes such as maturity-onset diabetes of the young (MODY). Differential diagnosis is complicated by the existence of intermediate phenotypes. We aimed to delineate the phenotypic continuum between …
be
(code pays fourni par la source)
2026
conference-paper
OpenAlex
Julie Harvengt, Muriel Hannon, Léonor Palmeira, Marie-Christine Lebrethon et autres
peer reviewed
Accès ouvert
2025
other
OpenAlex
André Jacques Scheen, Madeleine Wéra, Jean‐Christophe Philips, Julie Fudvoye et autres
Type 1 diabetes (T1D) is an autoimmune chronic disease that leads to the destruction of pancreatic beta cells and thus requires lifelong insulin therapy. Constraints and adverse events associated to insulin therapy are well known as well as the risk of long-term …
fr, be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Julie Harvengt, Léonor Palmeira, Marie-Christine Lebrethon, Vinciane Dideberg et autres
Introduction: Obesity is a major global health issue with multifactorial etiologies. Among them, recent advances in the comprehension of eating and energy regulation showed that around 60 genes involved in the hypothalamic leptin/melanocortin pathway contribute to the development of rare monogenic or …
be
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Caroline Gernay, Marie-Christine Lebrethon, Julie Fudvoye, Parent Anne-Simone
Accès ouvert
2025
article
OpenAlex
Jolien De Meulemeester, Laura Valgaerts, Guy Massa, Inge Gies et autres
CONTEXT: Real-world data add value to outcomes from randomized controlled trials on the use of hybrid closed-loop systems in the management of children and adolescents with type 1 diabetes. OBJECTIVE: This multicenter prospective observational cohort study assessed real-world changes in glycemic and …
be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
François Boemer, Kristine Hovhannesyan, Flávia Balbo Piazzon, Frédéric Minner et autres
The rapid development of therapies for severe and rare genetic conditions underlines the need to incorporate first-tier genetic testing into newborn screening (NBS) programs. A workflow was developed to screen newborns for 165 treatable pediatric disorders by deep sequencing of regions of …
be, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Julie Vandewalle, Aster K. Desouter, Bart J.R. Van der Auwera, Kaven B Chapaza et autres
Besides variation within the HLA gene complex determining a major part of genetic susceptibility to Type 1 diabetes, genome-wide association studies have identified over 60 non-HLA loci also contributing to disease risk. While individual single nucleotide polymorphisms (SNPs) have limited predictive power, …
be
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sophie Welsch, Antoine Harvengt, Paola Gallo, Manon Martin et autres
BACKGRUOUND: Recent diabetes subclassifications have improved the differentiation between patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus despite several overlapping features, yet without considering genetic forms of diabetes. We sought to facilitate the identification of monogenic diabetes by …
be
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Patrice Dufour, Catherine Pirard, Marie-Christine Lebrethon, Corinne Charlier
be
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Hilde Dotremont, Annick France, Claudine Heinrichs, Sylvie Tenoutasse et autres
Objectives: To improve adult height in pubertal girls with a poor height prediction, treatment with growth hormone (GH) can be used in combination with a gonadotropin releasing hormone agonist (GnRHa), to delay closure of the growth plates. However, there are few studies …
be
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Antoine Delfosse, Marieke den Brinker, Laurent Gatto, Inge Gies et autres
Abstract Current markers of β-cell function poorly reflect glucose homeostasis after diabetes onset, mainly because of the lack of integration of parameters of insulin sensitivity and β-cell responsiveness to glucose. Recently, the widespread use of continuous glucose monitoring (CGM) helped stratify glucose …